River Wealth Advisors’s ICU Medical ICUI Stock Holding History

River Wealth Advisors’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-50	Closed	-$11K	–	306
2018 Q4	$11K	Hold	50	–	–	﹤0.01%	411
2018 Q3	$14K	Hold	50	–	–	0.01%	416
2018 Q2	$15K	Buy	+50	New	+$13.7K	0.01%	400

Other funds holding ICUI

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

River Wealth Advisors's ICUI Position: Q1 2019 in Review

River Wealth Advisors sold out of ICU Medical (ICUI) in Q1 2019, closing a stake of 50 shares — an estimated $11K sold.

River Wealth Advisors first reported a position in ICUI in Q2 2018 and held it in 3 quarters. The position peaked at $15K in Q2 2018. 292 funds tracked by Wall St. Rank hold ICUI as of Q1 2019.

River Wealth Advisors reported no remaining ICU Medical position as of Q1 2019 after selling out during the quarter.
River Wealth Advisors sold 50 ICU Medical shares in Q1 2019, an estimated $11K.
River Wealth Advisors first reported a position in ICU Medical in Q2 2018 and held it in 3 quarters.
River Wealth Advisors's ICU Medical position peaked at $15K in Q2 2018.
292 funds tracked by Wall St. Rank held ICU Medical as of Q1 2019.

Based on River Wealth Advisors's 13F filing for Q1 2019, filed 7 May 2019.